Loading company…
Mendra develops therapeutics for rare and ultra-rare diseases using AI to support clinical development.
Mendra develops treatments for rare diseases and works with researchers, biotech companies and patient foundations to advance therapies. Founded in 2025 and based in San Francisco, the company raised USD 82 mn in Series A funding in January 2026, led by OrbiMed Advisors, 8VC and 5AM Ventures, with Lux Capital and Wing participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in